IL-13 antibody
Quick Overview for IL-13 antibody (ABIN1383954)
Target
See all IL-13 (IL13) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Recognises both natural and recombinant human IL-13
-
Purification
- Ion exchange chromatography
-
Sterility
- 0.22 μm filtered
-
Immunogen
- Recombinant human IL-13,Myeloma X63/AG.8653 x Balb/c spleen cells
-
Isotype
- IgG1 kappa
-
Biological Activity Comment
- Inhibits IL-13 induced proliferation on TF1 cell line
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
-
Preservative
- Without preservative
-
Storage
- 4 °C
-
Storage Comment
- Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
-
-
-
Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig." in: Blood, Vol. 101, Issue 8, pp. 3325-33, (2003) (PubMed).
: "Human eosinophils express and release IL-13 following CD28-dependent activation." in: Journal of leukocyte biology, Vol. 72, Issue 4, pp. 769-79, (2002) (PubMed).
: "Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 156, Issue 5, pp. 1818-23, (1996) (PubMed).
: "
-
Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig." in: Blood, Vol. 101, Issue 8, pp. 3325-33, (2003) (PubMed).
-
- IL-13 (IL13) (Interleukin 13 (IL13))
-
Alternative Name
- IL-13
-
Pathways
- JAK-STAT Signaling, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Proton Transport
Target
-